Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.

Qiang L, Yang Y, Ma YJ, Chen FH, Zhang LB, Liu W, Qi Q, Lu N, Tao L, Wang XT, You QD, Guo QL.

Cancer Lett. 2009 Jun 28;279(1):13-21. doi: 10.1016/j.canlet.2009.01.016. Epub 2009 Feb 15.

PMID:
19232461
2.

Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.

Wang J, Wang X, Jiang S, Lin P, Zhang J, Wu Y, Xiong Z, Ren JJ, Yang H.

Cell Mol Neurobiol. 2008 Nov;28(7):991-1003. doi: 10.1007/s10571-008-9273-2. Epub 2008 Mar 19.

PMID:
18350379
3.

NOTCH pathway blockade depletes CD133-positive glioblastoma cells and inhibits growth of tumor neurospheres and xenografts.

Fan X, Khaki L, Zhu TS, Soules ME, Talsma CE, Gul N, Koh C, Zhang J, Li YM, Maciaczyk J, Nikkhah G, Dimeco F, Piccirillo S, Vescovi AL, Eberhart CG.

Stem Cells. 2010 Jan;28(1):5-16. doi: 10.1002/stem.254.

4.

[Isolation and characterization of brain tumor stem cells in human medulloblastoma].

Li MC, Deng YW, Wu J, Chen FH, Liu JF, Fang JS.

Ai Zheng. 2006 Feb;25(2):241-6. Chinese.

PMID:
16480595
5.

BMI1 sustains human glioblastoma multiforme stem cell renewal.

Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G.

J Neurosci. 2009 Jul 15;29(28):8884-96. doi: 10.1523/JNEUROSCI.0968-09.2009.

6.

Isolation and partial characterization of a new human glioblastoma cell line.

Brehar FM, Bleotu C, Stefan LM, Buzgariu W, Chivu M, Utoiu E, Matei L, Ciurea AV, Tascu A.

Chirurgia (Bucur). 2009 Jul-Aug;104(4):453-61.

PMID:
19886054
7.

Bmi1 marks intermediate precursors during differentiation of human brain tumor initiating cells.

Venugopal C, Li N, Wang X, Manoranjan B, Hawkins C, Gunnarsson T, Hollenberg R, Klurfan P, Murty N, Kwiecien J, Farrokhyar F, Provias JP, Wynder C, Singh SK.

Stem Cell Res. 2012 Mar;8(2):141-53. doi: 10.1016/j.scr.2011.09.008. Epub 2011 Oct 8.

8.

Girdin maintains the stemness of glioblastoma stem cells.

Natsume A, Kato T, Kinjo S, Enomoto A, Toda H, Shimato S, Ohka F, Motomura K, Kondo Y, Miyata T, Takahashi M, Wakabayashi T.

Oncogene. 2012 May 31;31(22):2715-24. doi: 10.1038/onc.2011.466. Epub 2011 Oct 24.

PMID:
22020337
9.

Expression of multidrug resistance genes in normal and cancer stem cells.

Shervington A, Lu C.

Cancer Invest. 2008 Jun;26(5):535-42. doi: 10.1080/07357900801904140.

PMID:
18568776
10.

Effect of all-trans retinoic acid on the proliferation and differentiation of brain tumor stem cells.

Niu CS, Li MW, Ni YF, Chen JM, Mei JM, Li J, Fu XM.

J Exp Clin Cancer Res. 2010 Aug 17;29:113. doi: 10.1186/1756-9966-29-113.

11.

Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3.

Wan Y, Fei XF, Wang ZM, Jiang DY, Chen HC, Yang J, Shi L, Huang Q.

Chin J Cancer. 2012 Apr;31(4):207-14. doi: 10.5732/cjc.011.10336. Epub 2012 Feb 24.

12.

GSK3beta regulates differentiation and growth arrest in glioblastoma.

Korur S, Huber RM, Sivasankaran B, Petrich M, Morin P Jr, Hemmings BA, Merlo A, Lino MM.

PLoS One. 2009 Oct 13;4(10):e7443. doi: 10.1371/journal.pone.0007443.

13.

[Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].

Ping YF, Yao XH, Bian XW, Chen JH, Zhang R, Yi L, Zhou ZH.

Zhonghua Bing Li Xue Za Zhi. 2007 Mar;36(3):179-83. Chinese.

PMID:
17535685
14.

Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.

Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S.

Oncogene. 2011 Aug 4;30(31):3454-67. doi: 10.1038/onc.2011.58. Epub 2011 Mar 7.

15.

A novel fixative for immunofluorescence staining of CD133-positive glioblastoma stem cells.

Sherman JH, Redpath GT, Redick JA, Purow BW, Laws ER, Jane JA Jr, Shaffrey ME, Hussaini IM.

J Neurosci Methods. 2011 May 15;198(1):99-102. doi: 10.1016/j.jneumeth.2011.03.003. Epub 2011 Mar 23.

16.

[A novel adherent culture method of glioblastoma cells expressing CD133 using collagen-1-coated plates].

Motegi H, Kamoshima Y, Terasaka S, Kobayashi H, Houkin K.

Hokkaido Igaku Zasshi. 2012 Aug;87(4-5):147-51. Japanese.

PMID:
23016266
17.

CD133+ niches and single cells in glioblastoma have different phenotypes.

Christensen K, Schrøder HD, Kristensen BW.

J Neurooncol. 2011 Aug;104(1):129-43. doi: 10.1007/s11060-010-0488-y. Epub 2010 Dec 24.

PMID:
21184132
18.

Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo.

deCarvalho AC, Nelson K, Lemke N, Lehman NL, Arbab AS, Kalkanis S, Mikkelsen T.

Stem Cells. 2010 Feb;28(2):181-90. doi: 10.1002/stem.264.

19.

Glioma cell populations grouped by different cell type markers drive brain tumor growth.

Prestegarden L, Svendsen A, Wang J, Sleire L, Skaftnesmo KO, Bjerkvig R, Yan T, Askland L, Persson A, Sakariassen PØ, Enger PØ.

Cancer Res. 2010 Jun 1;70(11):4274-9. doi: 10.1158/0008-5472.CAN-09-3904. Epub 2010 May 11.

20.

Cancer stem cell labeling using poly(L-lysine)-modified iron oxide nanoparticles.

Wang X, Wei F, Liu A, Wang L, Wang JC, Ren L, Liu W, Tu Q, Li L, Wang J.

Biomaterials. 2012 May;33(14):3719-32. doi: 10.1016/j.biomaterials.2012.01.058. Epub 2012 Feb 18.

PMID:
22342710

Supplemental Content

Support Center